April 8 was the last update on clinical trials site to change status to recruiting. Six week stabilisation period. 20th May is 6 weeks.
So from tomorrow could hear of patients dosing, but doubt they would recruit on day 1.
Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS, page-13
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.015(3.41%) |
Mkt cap ! $242.0M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 46.5¢ | 44.0¢ | $951.8K | 2.110M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 75971 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 53815 | 11 |
View Market Depth
| Last trade - 13.11pm 09/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |